Clinical Trial Update: Azacitidine in Patients Undergoing Matched Unrelated Stem Cell Transplantation [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial of azacitidine in patients undergoing matched unrelated donor stem cell transplantation has been terminated; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia Myeloid Acute
• Myelodysplastic Syndromes
• Precursor Cell Lymphoblastic Leukemia-lymphoma

Drugs mentioned

• AZACITIDINE (AZACITIDINE)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Leukemia, Myeloid, Acute, Myelodysplastic Syndromes | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2019-10-16